Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 12:05 pm Sale |
2024-09-30 | 13G | Avalo Therapeutics, Inc. AVTX |
Allostery Investments LP | 55,840 0.500% |
-22,415 (-28.64%) |
Filing History |
| 2024-11-14 12:04 pm Purchase |
2024-09-30 | 13G | Oruka Therapeutics, Inc. ORKA |
Allostery Investments LP | 43,557 0.300% |
43,557 (New Position) |
Filing History |
| 2024-05-13 12:38 pm Purchase |
2024-05-01 | 13G | Avalo Therapeutics, Inc. AVTX |
Allostery Investments LP | 78,255 7.600% |
78,255 (New Position) |
Filing History |
| 2024-04-15 5:29 pm Purchase |
2024-04-03 | 13G | ARCA biopharma, Inc. ABIO |
Allostery Investments LP | 88,751 7.300% |
88,751 (New Position) |
Filing History |